SCHEMBL4992004

SCHEMBL4992004

CSC[C@@H](N)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL110459 1.00
SCHEMBL110458 1.00
SCHEMBL21489523 0.97 SLC7A5 (0.48)
Hydrochloric Acid SCHEMBL7756974 0.97
Hydrochloric Acid SCHEMBL28195056 0.97
Hydrochloric Acid SCHEMBL202708 0.97
SCHEMBL11582175 0.95 PTGS1 (0.50)
Chloroform SCHEMBL28222011 0.93 SLC7A5 (0.44)
Glycine SCHEMBL28312688 0.91 GLRA1 (0.46)
Cysteine SCHEMBL8936195 0.89 PTGS1 (0.70)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117186396-A Preparation method and application of sulfonium ionized antibacterial amino acid polymer 朱立中 2023-12-08 CN claimed
US-20230331779-A1 BISPECIFIC FUSION POLYPEPTIDE COMPOUND SHAANXI MICOT TECHNOLOGY CO., LTD. (CN) 2023-10-19 US claimed
EP-4212542-A1 BISPECIFIC FUSION POLYPEPTIDE COMPOUND Shaanxi Micot Technology Limited Company (CN) 2023-07-19 EP claimed
CN-115087662-A Bispecific fusion polypeptide compounds 陕西麦科奥特科技有限公司 2022-09-20 CN claimed
WO-2022052471-A1 BISPECIFIC FUSION POLYPEPTIDE COMPOUND 陕西麦科奥特科技有限公司 2022-03-17 WO claimed
US-7351398-B2 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers CIS BIO INTERNATIONAL (FR) 2008-04-01 US claimed
EP-1808184-A2 Stabilisation of radiopharmaceutical compositions using a hydrophilic thioether or a hydrophilic 6-hydroxy chroman CIS bio international (FR) 2007-07-18 EP claimed
EP-1381397-B1 STABILISATION OF RADIOPHARMACEUTICAL COMPOSITIONS USING A HYDROPHILIC THIOETHER OR A HYDROPHILIC 6-HYDROXY CHROMAN CIS BIO INT (FR) 2007-02-28 EP claimed
US-6989138-B2 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans DIATIDE, INC. (US) 2006-01-24 US claimed
US-20050180918-A1 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers DIATIDE, INC. 2005-08-18 US claimed
US-6902718-B2 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers DIATIDE, INC. (US) 2005-06-07 US claimed
US-20030072709-A1 Stabilization of radiopharmaceutical compositions using hydrophilic thioethers CIS BIO INTERNATIONAL (FR) 2003-04-17 US claimed
EP-0818463-B1 Aspartyl dipeptide amide derivatives and sweeteners AJINOMOTO KK (JP) 1999-09-29 EP claimed
US-5958496-A LOW CALORIE SWEETENING FOR FOOD, BEVERAGES; TASTE, STABILITY AJINOMOTO CO., INC. (JP) 1999-09-28 US claimed
EP-0818463-A1 Aspartyl dipeptide amide derivatives and sweeteners Ajinomoto Co., Ltd. (JP) 1998-01-14 EP claimed
US-4337247-A ANALGESICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1982-06-29 US claimed
US-20250276976-A1 CARDIAC SARCOMERE INHIBITORS CYTOKINETICS, INC. 2025-09-04 US disclosed
US-12275741-B2 Cardiac sarcomere inhibitors CYTOKINETICS, INC. (US) 2025-04-15 US disclosed
US-4277394-A ANALGESICS, ANTIDIARRHEA, TREATMENT OF MENTAL DISEASE TAKEDA CHEMICAL INDUSTRIES, LTD (JP) 1981-07-07 US disclosed
EP-0005248-A2 Tetrapeptidehydrazide derivatives and process for their preparation Takeda Chemical Industries, Ltd. (JP) 1979-11-14 EP disclosed